mHEALTH PRODUCTS

Cardiopulmonary Resuscitation (CPR), a standard in emergency medicine, has been in use since the 1960s. However, its effectiveness remains elusive in that a mere 4-20% of adults receiving CPR recover completely. Two primary components of CPR are chest compressions and then evaluating the effects of CPR. Assessing the effectiveness of Cardiopulmonary Resuscitation is an essential tool for Emergency Medical Technicians (EMT).

LifeWave Biomedical’s UWB radar technology can be implemented as a stand-alone device or incorporated with a defibrillator. Assessing the effectiveness of Cardiopulmonary Resuscitation is an essential tool for Emergency Medical Technicians (EMT) but current methods to assess the timing and depth of compressions are subjective, time-consuming and sensitive to motion. To address this critical need, LifeWave has developed a miniature Ultra-Wide Band (UWB) Radio Frequency (RF) medical radar for managing the application of CPR and assisting with cardiac resuscitation. We have developed signal processing algorithms that operate on UWB radar data collected from a patient’s chest. These specific algorithms analyze heart wall motion and changes in the chest cavity geometry to provide actionable information concerning the presence or absence of viable blood flow as well as feedback on the application of CPR. Furthermore, LifeWave’s UWB radar technology can be implemented as a stand-alone device or incorporated with a defibrillator. Thus, the administrator of CPR can be informed of the depth of chest compressions and simultaneously be informed of the resulting heart rate, blood pressure, stroke volume and respiration rate.

LifeWave has the opportunity to significantly improve the standard-of-care for heart failure disease management in the home and improving patient Quality-Adjusted-Life-Years (QALY). The sensor and analytics solution is designed to reduce hospitalization and related expense. Heart failure patients consume 34% of the annual Medicare budget and 42% of Medicare fee-for-service hospital admissions. LifeWave is addressing a significant clinical and economic need in heart failure management.

The LifeWave heart failure product combines both lung fluids and pulmonary assessment with analytics to enable provisioning of separate actionable information to the patient and to clinicians. The product is wearable or can be placed on the torso for spot measurement.

The LifeWave remote heart failure product is easily adapted to address hospital acute care, respiratory distress diseases, and respiratory rehabilitation, especially with COPD patients.